Browsing Tag
Nature Medicine
5 posts
ScreenPoint Medical bets on risk prediction and workflow AI after $16m funding boost
ScreenPoint Medical has raised $16 million to expand its breast imaging AI platform. Read why this funding could reshape screening and risk prediction.
Is elraglusib emerging as a new frontline option in metastatic PDAC?
Read how Actuate Therapeutics’ elraglusib Phase 2 survival data could reshape metastatic PDAC treatment and investor expectations.
Can pridopidine finally change the trajectory of Huntington’s disease progression?
Can pridopidine change the course of Huntington’s disease? Explore key data from the Nature Medicine study and what’s next for Prilenia’s regulatory path.
HER3-DXd shows promise in treating brain metastases: Inside the TUXEDO-3 trial results from ASCO 2025
HER3-DXd from Daiichi Sankyo and Merck shows intracranial activity in CNS cancers, as TUXEDO-3 results presented at ASCO 2025 spark major oncology interest.
Pfizer’s BRAFTOVI regimen doubles response rates for metastatic colorectal cancer
Pfizer Inc. has unveiled compelling findings from the Phase 3 BREAKWATER trial, highlighting the efficacy of its BRAFTOVI…